top
Search terms
Results 1 - 10 of 35 - ordered by :
Pages: 1 2 3 4
Ehjcardiovascrec

In the present studies, eprosartan's ability to provide end-organ protection was evaluated in a model of cardiomyopathy and renal failure in stroke-prone rats (SP). Echocardiographic (i.e. 2-D ...

Cardiovascular Research, Original Article, Frank C. Barone, Robert W. Coatney, Sudeep Chandra, Susanta K. Sarkar, Allen H. Nelson, Lisa C. Contino, David P. Brooks, Wallace G. Campbell, Eliot H. ...

Date : 01/06/2001 Item size : 322347 bytes
Ehjcardiovascrec

Introduction Cardiac hypertrophy is an adaptive response to a variety of mechanical and hormonal stimuli, such as hypertension, valvular heart disease, and ischaemic events.1,2 However, sustained ...

Cardiovascular Research, Cardiac biology and remodelling, Yi Liu, Xiao-Li Jiang, Yu Liu, Ding-Sheng Jiang, Yan Zhang, Rui Zhang, Yingjie Chen, Qinglin Yang, Xiao-Dong Zhang, Guo-Chang Fan, Hongliang ...

Date : 01/01/2014
Ehjcardiovascrec

Introduction The prevalence and mortality rate of heart failure dramatically increase in older people, and ageing is one of the risk factors for cardiovascular events.1 With ageing, the heart shows ...

Cardiovascular Research, Cardiac biology and remodelling, Tomofumi Misaka, Satoshi Suzuki, Makiko Miyata, Atsushi Kobayashi, Tetsuro Shishido, Akihito Ishigami, Shu-ichi Saitoh, Masamichi Hirose, ...

Date : 01/08/2013
Ehjcardiovascrec

Abstract Aims Sustained hypertension leads to cardiac hypertrophy that can progress, through pathological remodelling, to heart failure. Conclusion Low-level local AT1R activity in differentiated ...

Cardiovascular Research, Original Article, Justin F.X. Ainscough, Mark J. Drinkhill, Alicia Sedo, Neil A. Turner, David A. Brooke, Anthony J. Balmforth, Stephen G. Ball

Date : 15/02/2009
Ehjcardiovascrec

KeywordsArrhythmiasHypertrophyPropranololFibrosisHeart failureTime for primary review 41 days. 1 Introduction 1.1 Incidence of arrhythmias in cardiac hypertrophy Sudden death, presumably related to ...

Cardiovascular Research, Review, Patrick Assayag, François Carré, Brigitte Chevalier, Claude Delcayre, Pascale Mansier, Bernard Swynghedauw

Date : 01/06/1997
Ehjcardiovascrec

Abstract Objective: Treatment with the β-blocker carvedilol leads to an improvement of outcome and ejection fraction in heart failure. Results: β-Adrenoceptors were downregulated and ...

Cardiovascular Research, Original Article, Michael Böhm, Sylvia Ettelbrück, Markus Flesch, Wiek H van Gilst, Andreas Knorr, Christoph Maack, Yigal M Pinto, Martin Paul, Ard C.H Teisman, Oliver ...

Date : 01/10/1998
Ehjcardiovascrec

Methods: We investigated, in a single blinded, randomised, placebo-controlled, cross-over study of ten healthy male volunteers (mean age, 25.3±0.7 years), the effects of two weeks treatment with ...

Cardiovascular Research, Original Article, Ulrike Poller, Birgit Fuchs, Antje Gorf, Jens Jakubetz, Joachim Radke, Klaus Pönicke, Otto-Erich Brodde

Date : 01/10/1998
Ehjcardiovascrec

Introduction Numerous studies have demonstrated that heart failure and depression often coexist, and that depression is linked to the severity of heart failure symptoms.1,2 Heart failure and ...

Cardiovascular Research, Original Article, Koji Ito, Yoshitaka Hirooka, Ryuichi Matsukawa, Masatsugu Nakano, Kenji Sunagawa

Date : 01/01/2012
Ehjcardiovascrec

The mechanisms involved in the loss of physiological daynight variation are still unclear, but a continuously active sympathetic nervous system could play a role. The present study evaluated ...

Cardiovascular Research, Original Article, Klaus Witte, Kai Hu, Johanna Swiatek, Claudia Müssig, Georg Ertl, Björn Lemmer

Date : 01/08/2000
Ehjcardiovascrec

Antihypertensive drugs that increase NO generation or that inhibit endothelin production have been shown to decrease cardiac hypertrophy (mostly by decreasing LVH), thus preventing heart failure ...

Cardiovascular Research, Editorial, Alexandre D.T. Costa

Date : 01/08/2009